Welcome to Investor Relations
—Welcome to the Investor Relations page for Drägerwerk AG & Co. KGaA. Here you can find more information about our company profile, reasons to invest, our company goals, and our markets.
We stand for ›Technology for Life‹
—Dräger manufactures medical and safety technology products. By doing so, we protect, support, and save the lives of people in hospitals, fire departments, rescue services, government agencies, mining, and industry around the world. The family-run company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a global, publicly traded group. Dräger employs more than 16,000 people worldwide and is currently represented in over 190 countries. In 2024, the company generated net sales of around EUR 3.4 billion. Dräger technology is used all over the world. We operate in around 50 countries with our own sales and service companies directly on location where our customers are.
Reasons to invest in Dräger
—
Flexible—even in times of crisis
Switch to a multiple-shift schedule, ramp-up of production capacities, and development and opening of new production sites after the onset of the coronavirus pandemic.

Quality and innovation
The Dräger brand is known worldwide for quality and innovation.

Values
Dräger combines a modern approach to management with the values of a family-run company.

A global leader
Dräger is a global leader in the fields of medical and safety technology.

Technology for Life
Dräger provides products that protect, support, and save lives.

Global network
Dräger has formed well-established customer relationships over many years through its global sales and service network.
Company goals
—Medium-term company goals
Our medium-term company goals are based on our corporate aspirations and are aligned with financial and non-financial targets. While defining our current goals, we determined the following priorities:
Expectations for fiscal year 2025
—Results achieved for fiscal year 2024 | Forecast for fiscal year 2025 | |
Net sales (net of currency effects) | 0.5% | 1.0 to 5.0% |
EBIT margin | 5.8% | 3.5 to 6.5% |
DVA | EUR 54.3 million | EUR -30 to 80 million |
Gross margin | 44.9% | 44.0 to 46.0% |
R&D expenses | EUR 333.1 million | EUR 330 to 350 million |
Net financial debt | EUR 165.0 million | EUR 180 to 210 million |
Investment volume1 | EUR 76.0 million | EUR 110 to 130 million |
Interest result | EUR -18.6 million | EUR -17 to -23 million |
Days Working Capital (DWC) | 108.2 days | 105 to 110 days |
1 Excluding acquisitions and the capitalization of right-of-use assets pursuant to IFRS 16
Our markets
—Medical
As a specialist for acute care, our aim is to optimize critical care. Because our focus is on the satisfaction of hospital staff and the well-being of patients in addition to improving clinical results and optimizing treatment costs, Dräger has been passionate about developing technologies, products, expertise, and services for critical care that help hospitals achieve their goals for over 130 years.
Safety
Dräger Safety offers a wide range of safety products such as mobile and fixed gas detection devices, as well as personal protective equipment. A global sales network and more than 130 years of experience underpin Dräger’s outstanding reputation in the field of safety technology. For small-scale enterprises and major corporations alike, Dräger has the ideal solution for every situation and helps protect employees, equipment, and systems.
Related topics
—
Dräger share
This page provides information on our shareholder structure, share charts, share indicators, dividends, analyst recommendations, participation certificates, and the employee share program.

Financial calendar and publications
Here you will find current financial results and reports, as well as ad hoc announcements, capital market information and other financial publications.

Corporate Governance
Here you will find the declaration of compliance, notifications of proprietary transactions, and the articles of association of Drägerwerk AG & Co. KGaA.
Contact Dräger
—
